Estadístiques de Immunomodulatory effects of lenvatinib plus anti-programmed cell death protein 1 in mice and rationale for patient enrichment in hepatocellular carcinoma
Visites totals
| views | |
|---|---|
| Immunomodulatory effects of lenvatinib plus anti-programmed cell death protein 1 in mice and rationale for patient enrichment in hepatocellular carcinoma | 98 |
Visites totals per mes
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 1 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Torrens_hep_immu.pdf(legacy) | 308 |
| Torrens_hep_immu.pdf | 113 |
Vistes principals per país
| views | |
|---|---|
| United States | 64 |
| Spain | 6 |
| Belgium | 3 |
| Australia | 2 |
| Germany | 2 |
| France | 2 |
| Argentina | 1 |
| Ireland | 1 |
| Malaysia | 1 |
| Sweden | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 22 |
| Menlo Park | 10 |
| Ann Arbor | 7 |
| Boardman | 6 |
| Barcelona | 3 |
| Fairfield | 3 |
| Mountain View | 3 |
| Berlin | 2 |
| Castellbisbal | 1 |
| Dublin | 1 |
| Federal | 1 |
| Málaga | 1 |
| Petaling Jaya | 1 |
| Sevilla | 1 |